As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоСлучаи кори в США в 2026 году?
Случаи кори в США в 2026 году?
$7,669,925 Объем
$7,669,925 Объем
31 дек. 2026 г.
↑2к
99%
↑3к
62%
↑4k
28%
↑5к
14%
↑7,5 тыс.
14%
↑10k
10%
↑12,5 тыс.
5%
$7,669,925 Объем
$7,669,925 Объем
31 дек. 2026 г.
↑2к
$45,436 Объем
99%
↑3к
$50,414 Объем
62%
↑4k
$170,864 Объем
28%
↑5к
$215,382 Объем
14%
↑7,5 тыс.
$174,338 Объем
14%
↑10k
$6,493,892 Объем
10%
↑12,5 тыс.
$344,846 Объем
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Открытие рынка: Feb 16, 2026, 11:51 AM ET
Объем
$7,669,925Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Объем
$7,669,925Дата окончания
31 дек. 2026 г.Открытие рынка
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early May 2026, the CDC has confirmed 1,842 measles cases in the United States, on pace to exceed 2025’s full-year total of 2,288, with 93% tied to ongoing outbreaks across 36 states. This resurgence stems from sustained declines in MMR vaccination coverage, leaving clusters of unvaccinated children and adolescents vulnerable to highly transmissible airborne spread from imported cases. Official data show 72% of 2026 infections occurring in those under 20, with most linked to domestic outbreaks rather than travel alone. Weekly CDC surveillance updates on new case counts, outbreak expansions, and vaccination status distributions will continue to shape trader assessments of whether the year-end total surpasses or falls short of recent highs.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы